These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25796629)

  • 1. Osteoclasts are not activated in middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
    J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.
    Xie S; Jin L; Fu J; Yuan Q; Yin T; Ren J; Liu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May; 49(5):655-666. PubMed ID: 39174879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
    Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
    Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
    Zupan J; Komadina R; Marc J
    J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma].
    Ma Y; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(7):293-5. PubMed ID: 18589796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
    Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
    Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium fluoride induces hypercalcemia resulting from the upregulation of both osteoblastic and osteoclastic activities in goldfish, Carassius auratus.
    Sato M; Hanmoto T; Yachiguchi K; Tabuchi Y; Kondo T; Endo M; Kitani Y; Sekiguchi T; Urata M; Hai TN; Srivastav AK; Mishima H; Hattori A; Suzuki N
    Comp Biochem Physiol C Toxicol Pharmacol; 2016 Nov; 189():54-60. PubMed ID: 27475026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
    Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
    Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS; Ma CJ; Kim DS; Ma JY
    J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal bone architecture in mice expressing MyD88 in cells of the osteoclast lineage.
    Suren C; Lukashova L; Wischmann J; Wulsten D; Wildemann B; Von Eisenhart-Rothe R; Holzmann B; Mayer-Kuckuk P
    J Biol Regul Homeost Agents; 2019; 33(4):1105-1111. PubMed ID: 31332987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma].
    Xia M; Ding S; Zhang H; Liu F; Yin H; Xu A
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(7):315-7. PubMed ID: 17580719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
    J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
    Fioramonti M; Santini D; Iuliani M; Ribelli G; Manca P; Papapietro N; Spiezia F; Vincenzi B; Denaro V; Russo A; Tonini G; Pantano F
    Oncotarget; 2017 Mar; 8(12):20113-20121. PubMed ID: 28223547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.